These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36100820)

  • 1. Determinants of COVID-19 Vaccine Rollouts and Their Effects on Health Outcomes.
    Deb P; Furceri D; Jimenez D; Kothari S; Ostry JD; Tawk N
    Appl Health Econ Health Policy; 2023 Jan; 21(1):71-89. PubMed ID: 36100820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The COVID-19 Vaccination and Vaccine Inequity Worldwide: An Empirical Study Based on Global Data.
    Ning C; Wang H; Wu J; Chen Q; Pei H; Gao H
    Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of adjusting public health, travel, and social measures during the roll-out of COVID-19 vaccination: a modelling study.
    Leung K; Wu JT; Leung GM
    Lancet Public Health; 2021 Sep; 6(9):e674-e682. PubMed ID: 34388389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case for Cross-Border Governance? A Comparative Trend Assessment of COVID-19 Transmission, Vaccination, and Outcomes Among 35 Nations in Europe Across 18 months.
    Cuschieri S; Cuschieri A; Farrugia E; Diacono E; Balzan E; Grupetta M; Vella A; Cutajar C; Formosa M; Barbara M; Mintoff F; Shaw C; Fleri-Soler S; Borg N; Pace G; Vella L; Pisani R; Attard-Mallia T; Gouder M; Attard R; Grixti N; Scicluna M; Borda T; Bartolo K; Chircop R; Degabrielle-Ferrante E; Mallia M; Attard M; Frendo N; Gatt G; Damato G; Riolo N; Muscat-Baron L; Galea M; Grech E
    Disaster Med Public Health Prep; 2022 May; 17():e196. PubMed ID: 35492012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling the potential economic benefits of an oral SARS-CoV-2 vaccine during an outbreak of COVID-19.
    Patenaude B; Ballreich J
    BMC Public Health; 2022 Sep; 22(1):1792. PubMed ID: 36131266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of access to the SARS-CoV-2 vaccine: a preliminary approach.
    de Oliveira BRB; da Penha Sobral AIG; Marinho MLM; Sobral MFF; de Souza Melo A; Duarte GB
    Int J Equity Health; 2021 Aug; 20(1):183. PubMed ID: 34391416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of delayed access to COVID-19 vaccines in low- and lower-middle-income countries.
    Duroseau B; Kipshidze N; Limaye RJ
    Front Public Health; 2022; 10():1087138. PubMed ID: 36711400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 case doubling time associated with non-pharmaceutical interventions and vaccination: A global experience.
    Liang LL; Kao CT; Ho HJ; Wu CY
    J Glob Health; 2021; 11():05021. PubMed ID: 34552726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is COVID-19 vaccine inequality undermining the recovery from the COVID-19 pandemic?
    Suárez-Álvarez A; López-Menéndez AJ
    J Glob Health; 2022 May; 12():05020. PubMed ID: 35604879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal changes in COVID-19 vaccination intent among South African adults: evidence from the NIDS-CRAM panel survey, February to May 2021.
    Burger R; Köhler T; Golos AM; Buttenheim AM; English R; Tameris M; Maughan-Brown B
    BMC Public Health; 2022 Mar; 22(1):422. PubMed ID: 35236319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Surveillance in the Middle East and North Africa: Longitudinal Trend Analysis.
    Post L; Marogi E; Moss CB; Murphy RL; Ison MG; Achenbach CJ; Resnick D; Singh L; White J; Boctor MJ; Welch SB; Oehmke JF
    J Med Internet Res; 2021 Jan; 23(1):e25830. PubMed ID: 33302252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis.
    Liu Q; Qin C; Liu M; Liu J
    Infect Dis Poverty; 2021 Nov; 10(1):132. PubMed ID: 34776011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of COVID-19 Vaccinations With Intensive Care Unit Admissions and Outcome of Critically Ill Patients With COVID-19 Pneumonia in Lombardy, Italy.
    Grasselli G; Zanella A; Carlesso E; Florio G; Canakoglu A; Bellani G; Bottino N; Cabrini L; Castelli GP; Catena E; Cecconi M; Cereda D; Chiumello D; Forastieri A; Foti G; Gemma M; Giudici R; Grazioli L; Lombardo A; Lorini FL; Madotto F; Mantovani A; Mistraletti G; Mojoli F; Mongodi S; Monti G; Muttini S; Piva S; Protti A; Rasulo F; Scandroglio AM; Severgnini P; Storti E; Fumagalli R; Pesenti A;
    JAMA Netw Open; 2022 Oct; 5(10):e2238871. PubMed ID: 36301541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Retrospective Global Assessment of Factors Associated With COVID-19 Policies and Health Outcomes.
    Choi AJ; Hean AC; Lee JK; Tran ND; Lin TK; Apollonio DE
    Front Public Health; 2022; 10():843445. PubMed ID: 35615034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of COVID-19 Vaccine Hesitancy: A Cross-Sectional Study on a Mexican Population Using an Online Questionnaire (COV-AHQ).
    Delgado-Gallegos JL; Padilla-Rivas GR; Zúñiga-Violante E; Avilés-Rodríguez G; Arellanos-Soto D; Gastelum-Arias LJ; Franco Villareal H; Cosío-León MLÁ; Romo-Cardenas GS; Moreno-Treviño MG; Moreno-Cuevas JE; Islas JF
    Front Public Health; 2021; 9():728690. PubMed ID: 34900890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Overview of Strategies to Improve Vaccination Compliance before and during the COVID-19 Pandemic.
    Charrier L; Garlasco J; Thomas R; Gardois P; Bo M; Zotti CM
    Int J Environ Res Public Health; 2022 Sep; 19(17):. PubMed ID: 36078757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility to Resurgent COVID-19 Outbreaks Following Vaccine Rollouts: A Modeling Study.
    Neofotistos G; Angeli M; Mattheakis M; Kaxiras E
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unfolding the Determinants of COVID-19 Vaccine Acceptance in China.
    Yin F; Wu Z; Xia X; Ji M; Wang Y; Hu Z
    J Med Internet Res; 2021 Jan; 23(1):e26089. PubMed ID: 33400682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.